Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial

Background: In vitro studies have shown that several oral antiseptics have virucidal activity against SARS-CoV-2. Thus, mouthwashes have been proposed as an easy to implement strategy to reduce viral transmission. However, there are no data measuring SARS-CoV-2 viability after mouthwashes in vivo. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez Barrueco, Álvaro, Mateos-Moreno, María Victoria, Martínez-Beneyto, Yolanda, García-Vázquez, Elisa, Campos González, Alfonso, Zapardiel Ferrero, Javier, Bogoya Castaño, Abel, Alcalá Rueda, Ignacio, Villacampa Aubá, José Miguel, Cenjor Español, Carlos, Moreno-Parrado, Laura, Ausina-Márquez, Verónica, García-Esteban, Sandra, Artacho, Alejandro, López-Labrador, F. Xavier, Mira, Alex, Ferrer, María D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336498/
https://www.ncbi.nlm.nih.gov/pubmed/35796097
http://dx.doi.org/10.1080/22221751.2022.2098059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336498/
https://www.ncbi.nlm.nih.gov/pubmed/35796097
http://dx.doi.org/10.1080/22221751.2022.2098059

Ejemplares similares